Trevian Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,456
Closed -$679K 41
2025
Q2
$679K Buy
+5,456
New +$694K 0.41% 22
2024
Q4
Sell
-1,501
Closed -$223K 30
2024
Q3
$223K Buy
+1,501
New +$215K 0.18% 27
2024
Q2
Sell
-1,501
Closed -$276K 17
2024
Q1
$276K Sell
1,501
-600
-29% -$114K 0.19% 26
2023
Q4
$378K Buy
+2,101
New +$327K 0.29% 21

Other funds holding RGEN

Trevian Wealth Management's RGEN Position: Q3 2025 in Review

Trevian Wealth Management sold out of Repligen (RGEN) in Q3 2025, closing a stake of 5,456 shares — an estimated $679K sold.

Trevian Wealth Management first reported a position in RGEN in Q4 2023 and held it in 4 quarters. The position peaked at $679K in Q2 2025. 451 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Trevian Wealth Management reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Trevian Wealth Management sold 5,456 Repligen shares in Q3 2025, an estimated $679K.
  • Trevian Wealth Management first reported a position in Repligen in Q4 2023 and held it in 4 quarters.
  • Trevian Wealth Management's Repligen position peaked at $679K in Q2 2025.
  • 451 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Trevian Wealth Management's 13F filing for Q3 2025, filed 23 Oct 2025.